Pregnancy

Genetic Testing Company JunoDx Launches Juno Hazel, Its Non-invasive Prenatal Screening Solution

Genetic testing company JunoDx has announced the launch of Juno Hazel, a new non-invasive prenatal screening (NIPS) solution enabled from finger-prick amounts of blood. The Juno Hazel test breaks through one of the most significant barriers to access for genetic testing by leveraging JunoDx’s proprietary Sample Collection Kit. This process improves early access to high-quality genetic testing without the high costs, long…

Fitness and Health Tracker WHOOP Identifies a Novel Pregnancy Digital Biomarker to Screen for Premature Birth

WHOOP has uncovered a new pregnancy digital biomarker for noninvasive prescreening for premature birth. In the United States, preterm birth is the second leading cause of infant mortality and 35.8% of all infant deaths are preterm-related. In a new study in peer review led by WHOOP Senior Vice President of Data Science & Research, Emily Capodilupo, WHOOP analyzed the physiological data of 241 pregnancies and found that…

Mirvie’s First “Future of Pregnancy Health” Report Reveals What New or Expecting Moms Want from Pregnancy Care

Mirvie is shaping the future of pregnancy health by providing women, expecting parents and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis. One in five pregnancies is impacted by complications that lead to lifelong health consequences for expecting parents and babies. The proprietary company’s RNA platform uses a simple blood test to reveal vital…

March of Dimes Launches a New Data-Focused Prematurity Research Center at UCSF

March of Dimes, the leading organization fighting for the health of all moms and babies, is has opened the March of Dimes Prematurity Research Center (PRC) at UC San Francisco (UCSF). This new PRC, which will focus on prematurity data sharing, computational drug discovery and electronic medical record research, is part of the organization’s shift to speed the pace of discovery to…

Quest Adds Hepatitis C Screening to Its New Maternal Health Obstetrics Test Panel

Hepatitis C is the most common bloodborne infection in the United States and is a leading cause of liver-related morbidity and mortality. An estimated 1,700 infants were born with HCV infection (acquired in utero) each year between 2011 and 2014. Yet a recent Quest Diagnostics Health Trends study published in Obstetrics and Gynecology in June 2022 found that less than 41% of pregnant people were…

Nuvo and Sheba Medical Center Partner to Evaluate a New Virtual Care Regimen for the Management of Gestational Diabetes

Nuvo Group, the company behind INVU, an FDA-approved remote pregnancy monitoring platform, and Israeli Sheba Medical Center have partnered to evaluate a new virtual care regimen for the management of gestational diabetes. The first phase of the collaboration has now been completed. As part of the pilot program medically necessary non-stress tests (NSTs) were shifted to home-based, remote monitoring using INVU rather than…

Proov Launches New hCG Tests for Early Pregnancy Detection

Proov, known for its PdG-test and full cycle tracking kit is launching another product: The Proov Check Early Pregnancy Test. The new test allows women to use the tests up to five days before their next expected period to detect hCG (human Chorionic Gonadotropin) in urine, which is only present when pregnant. Results can be expected within 5 minutes of taking the…

Biotech Company Mirvie Raises $60M for Its RNA Platform Focused on Early Prediction of Pregnancy Complications

Mirvie‘s proprietary RNA platform combines revolutionary analysis of tens of thousands of RNA messages from the baby, the placenta and the mom, with machine learning. The platform opens a new window into pregnancy health for expecting parents to act and their doctors to intervene before unexpected complications become a crisis. It can predict preeclampsia and preterm birth months before they happen by…